Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thymosin beta4: a new molecular target for antitumor strategies.

Literature DB >> 14625249

Thymosin beta4: a new molecular target for antitumor strategies.

Allan L Goldstein.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2003 PMID： 14625249 DOI： 10.1093/jnci/djg126

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Molecular cloning and structural characterization of the functional human thymosin beta4 gene.

Authors: Shu-Ping Yang; Hui-Ju Lee; Yeu Su
Journal: Mol Cell Biochem Date: 2005-04 Impact factor: 3.396

Review 2. Adamantinomatous craniopharyngioma: advances in proteomic research.

Authors: Claudia Desiderio; Diana Valeria Rossetti; Massimo Castagnola; Luca Massimi; Gianpiero Tamburrini
Journal: Childs Nerv Syst Date: 2020-07-02 Impact factor: 1.475

3. Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator.

Authors: Eun-Yi Moon; Yun-Sun Im; Yun-Kyoung Ryu; Joo-Hyun Kang
Journal: Clin Exp Metastasis Date: 2010-09-07 Impact factor: 5.150

4. Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

Authors: Jo Caers; Dirk Hose; Ine Kuipers; Tomas Jan Bos; Els Van Valckenborgh; Eline Menu; Elke De Bruyne; Hartmut Goldschmidt; Ben Van Camp; Bernard Klein; Karin Vanderkerken
Journal: Haematologica Date: 2009-10-14 Impact factor: 9.941

5. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation.

Authors: Yuqing Zhang; Louis W Feurino; Qihui Zhai; Hao Wang; William E Fisher; Changyi Chen; Qizhi Yao; Min Li
Journal: Cancer Biol Ther Date: 2007-12-13 Impact factor: 4.742

6. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.

Authors: Claudia Desiderio; Claudia Martelli; Diana Valeria Rossetti; Concezio Di Rocco; Luca D'Angelo; Massimo Caldarelli; Gianpiero Tamburrini; Federica Iavarone; Massimo Castagnola; Irene Messana; Tiziana Cabras; Gavino Faa
Journal: Childs Nerv Syst Date: 2013-03-17 Impact factor: 1.475

Thymosin beta4: a new molecular target for antitumor strategies.

1. Molecular cloning and structural characterization of the functional human thymosin beta4 gene.

Review 2. Adamantinomatous craniopharyngioma: advances in proteomic research.

3. Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator.

4. Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.

5. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation.

6. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.

7. Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells.

8. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response.

Review 9. Potential role of thymosin Beta 4 in liver fibrosis.

10. The Escherichia coli-derived thymosin β4 concatemer promotes cell proliferation and healing wound in mice.